Abhineet Kumar, Business Standard

Abhineet Kumar

Business Standard

Mumbai, MH, India

Contact Abhineet

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Business Standard

Past articles by Abhineet:

Abbott India gets aggressive on new product launches, plans 110 in 5 years

Read more about Abbott India gets aggressive on new product launches, plans 110 in 5 years on Business Standard. The pharma firm, which had launched 14 products last year, is using social media to get into sub-therapies → Read More

India's leadership in cost-efficient generics is unchallenged: Sanjiv Kaul

Read more about India's leadership in cost-efficient generics is unchallenged: Sanjiv Kaul on Business Standard. Price erosion has been in excess of 15 per cent last year and will perhaps be at similar levels this year due to sales channel consolidation, says Kaul → Read More

Aurobindo Pharma wrests second position among drug firms from Lupin

Read more about Aurobindo Pharma wrests second position among drug firms from Lupin on Business Standard. While Lupin recorded a 10.6 per cent decline in its sales for the period, the largest, Sun Pharma, recorded a 17.4 per cent fall → Read More

Ola cabs rank third among venture capital funding for Dec quarter

Read more about Ola cabs rank third among venture capital funding for Dec quarter on Business Standard. The top of the chart is occupied by Ola cabs' Chinese peer Didi Chuxing, China Internet Plus is second on the list → Read More

Top 20 club: RIL has mountains to climb

Read more about Top 20 club: RIL has mountains to climb on Business Standard. The firm would require it to more than triple its CAGR of revenue to 18.5% for the next decade from 6% → Read More

Crorepati CEO club grew 18% last fiscal year

Read more about Crorepati CEO club grew 18% last fiscal year on Business Standard. The top slot on the list was captured by A M Naik, group chairman, Larsen & Toubro (L&T), with a compensation of Rs 78.9 crore in 2016-17 → Read More

Realty lenders turn to white knights

Read more about Realty lenders turn to white knights on Business Standard. L&T Realty, Godrej & Prestige see spurt in ventures with banks → Read More

How red tape over a dengue vaccine avoided a health crisis

Read more about How red tape over a dengue vaccine avoided a health crisis on Business Standard. The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia aggravates symptoms in some cases → Read More

Retailers go to small towns for big growth

Read more about Retailers go to small towns for big growth on Business Standard. Reliance Digital has established its presence in more than 100 cities and plans to expand further → Read More

Investors shun real estate but lap up realty stocks

Read more about Investors shun real estate but lap up realty stocks on Business Standard. See affordable housing as the next big thing → Read More

Insolvency Code ordinance: Promoters' loss is PEs' gain

Read more about Insolvency Code ordinance: Promoters' loss is PEs' gain on Business Standard. The ordinance has barred most promoters of the defaulting firms from bidding for their assets in the bankruptcy auction → Read More

Beating GST: Retailers surprise with huge y-o-y growth

Read more about Beating GST: Retailers surprise with huge y-o-y growth on Business Standard. Future Retail reported Rs 153 crore net profit for the quarter, 108% year-on-year growth → Read More

Google, Just Dial in deal talks

Read more about Google, Just Dial in deal talks on Business Standard. Acquisition to increase the technology giant's database by 20 million listings → Read More

Telcos, PE firms show interest in RCom assets

Read more about Telcos, PE firms show interest in RCom assets on Business Standard. RCom has suggested its consortium of banks convert part of their loans into a 51 per cent majority equity in the truncated company → Read More

Four pharma firms face US price-fixing charge

Read more about Four pharma firms face US price-fixing charge on Business Standard. US lawmakers turn the heat on Dr Reddy's, Glenmark, Sun Pharma and Emcure → Read More

Treating mental health: The way to a cure begins with conversation

Read more about Treating mental health: The way to a cure begins with conversation on Business Standard. The mental health of children and adolescents has suddenly become a cause of concern in India - with good reason → Read More

PE firms make record exits of $9.4 billion in 2017

Read more about PE firms make record exits of $9.4 billion in 2017 on Business Standard. Investments too at an all-time high of $19.5 billion in the first nine months of the calendar year → Read More

Sun Pharmaceutical, Dr Reddy's line up new drugs amid price war

Read more about Sun Pharmaceutical, Dr Reddy's line up new drugs amid price war on Business Standard. Arm themselves with speciality and complex drugs facing less competition → Read More

Birla's e-tail exits may not deter other retailers

Read more about Birla's e-tail exits may not deter other retailers on Business Standard. Bricks-and-mortar retailers with unique online offerings better placed to fight → Read More

Mistrys to vote against Tata Sons move to become a private limited company

Read more about Mistrys to vote against Tata Sons move to become a private limited company on Business Standard. Ousted Tata Sons chairman Cyrus Mistry will move the NCLT against the resolution → Read More